Stock comparison
Medtronic
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.84B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$26.47B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 62C | MTD |
| Benjamin Graham | 57C | 38D | MDT |
| Philip Fisher | 44D | 57C | MTD |
| Peter Lynch | 49D | 52C | MTD |
| Joel Greenblatt | 33F | 65B | MTD |
| Charlie Munger | 45D | 65B | MTD |
| Terry Smith | 46D | 64C | MTD |
Side-by-side metrics
| Metric | MDT | MTD |
|---|---|---|
| Market cap | $97.84B | $26.47B |
| P/E (TTM) | 21.2x | 30.5x |
| EV/EBIT | 21.0x | 25.7x |
| ROIC (TTM) | 6.43% | 35.46% |
| Gross margin | 61.95% | 57.52% |
| Net margin | 13.0% | 21.59% |
| Revenue CAGR 5y | 2.73% | 2.01% |
| EPS CAGR 5y | 7.88% | 6.12% |
| Debt / Equity | 0.6x | - |
| Dividend yield | 3.73% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- Dividend yield3.73%vs 0.0%+100%
- Market cap$97.84Bvs $26.47B+73%
- P/E (TTM)21.2xvs 30.5x+31%
- Revenue CAGR 5y2.73%vs 2.01%+26%
MTD leads on
- Debt / Equity-vs 0.6x+101%
- ROIC (TTM)35.46%vs 6.43%+82%
- Net margin21.59%vs 13.0%+40%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.